2208750
Project Grant
Overview
Grant Description
Sbir Phase I: A Radio Frequency Quadrupole Stark Decelerator to Identify Isomers and Conformers and Measure Their Effective Dipole Moments - The Broader Impact/Commercial Potential of This Small Business Innovation Research (SBIR) Phase I Project Will Lead to a New Type of Analytical Instrument and Associated Businesses, Specializing in the Identification and Characterization of Chemical Isomers and Their Different Conformational Forms (Conformers).
Isomers Are Molecules with the Same Constituent Atoms but Arranged Differently. The Identification of Isomers and Their Conformational Forms Is of Critical Importance to Pharmaceutical and Agrochemical Industries Since the Metabolites of Many Medications or Agrochemical Compounds Are Often Isomers of One Another. Since Some of These Metabolites May Be Harmful, Safety and Efficacy Studies Require Careful Analytical Method Development Work to Quantitate Their Presence in Clinical Samples, Soils, and Foodstuffs.
Unfortunately, Current Analytical Methods for Identifying Molecular Isomers Are Cumbersome, Slow, and Involve Trial and Error Work - Presenting a Significant Bottleneck to Regulatory Approval. The Proposed Technology Seeks to Provide a Rapid and Robust Instrument for Isomer Analysis, Dramatically Reducing Pharmaceutical and Agrochemical Development Costs and Extending Patent Exclusivity Sales - While Enabling the Experimental Identification of Conformers for the First Time.
Access to This New Information Has the Potential to Transform Agrochemical ($220 Billion Total Addressable Market (TAM) in 2022) and Drug Discovery ($82 Billion TAM 2022) Sectors, While Generating New Well-Paying, High-Tech Jobs.
This SBIR Phase I Project Proposes to Develop a Novel Mass Spectrometer That Works on Neutral Molecules Rather Than Ions. It Uses High Electric Fields to Manipulate and Distinguish Molecules, Separating Them by the Magnitude of Their Electrical Polarity Which, in Turn, Is Highly Sensitive to the Molecule's 3D Shape.
Molecules May Be Pushed or Pulled by the Fields Depending on Their Orientations in the Field and the Magnitude of Their Polarity (Dipole Moment). Since Molecular Isomers Weigh the Same, Their Identification via Mass Spectrometry Is Complicated and Typically Requires Time-Consuming Method Development Work.
The Proposed Instrument Aims to Reduce This Work by Using Dipole Moments to Distinguish All Isomers and Their Conformers in a Single Spectrum - with an Axis Labeled by Mass-to-Dipole-Moment Ratio, Rather Than Mass-to-Charge Ratio.
This Technology Uses Microfabrication Techniques to Miniaturize and Planarize a Previously Demonstrated Quadrupole Device Described in the Academic Literature, Creating an Array of Microscopic Quadrupole Channels. The Additional Patent-Pending Deceleration Feature, Coupled with Velocity Selective Detection, Should Result in 2-to-3 Orders of Magnitude Higher Isomer/Conformer Discrimination Capabilities Over the Literature Device.
Finally, This Universal Detection Methodology Will Allow for Continuous Throughput, Which Is Ideal for Interfacing with Standard Analytical Instrumentation.
This Award Reflects NSF's Statutory Mission and Has Been Deemed Worthy of Support Through Evaluation Using the Foundation's Intellectual Merit and Broader Impacts Review Criteria.
Isomers Are Molecules with the Same Constituent Atoms but Arranged Differently. The Identification of Isomers and Their Conformational Forms Is of Critical Importance to Pharmaceutical and Agrochemical Industries Since the Metabolites of Many Medications or Agrochemical Compounds Are Often Isomers of One Another. Since Some of These Metabolites May Be Harmful, Safety and Efficacy Studies Require Careful Analytical Method Development Work to Quantitate Their Presence in Clinical Samples, Soils, and Foodstuffs.
Unfortunately, Current Analytical Methods for Identifying Molecular Isomers Are Cumbersome, Slow, and Involve Trial and Error Work - Presenting a Significant Bottleneck to Regulatory Approval. The Proposed Technology Seeks to Provide a Rapid and Robust Instrument for Isomer Analysis, Dramatically Reducing Pharmaceutical and Agrochemical Development Costs and Extending Patent Exclusivity Sales - While Enabling the Experimental Identification of Conformers for the First Time.
Access to This New Information Has the Potential to Transform Agrochemical ($220 Billion Total Addressable Market (TAM) in 2022) and Drug Discovery ($82 Billion TAM 2022) Sectors, While Generating New Well-Paying, High-Tech Jobs.
This SBIR Phase I Project Proposes to Develop a Novel Mass Spectrometer That Works on Neutral Molecules Rather Than Ions. It Uses High Electric Fields to Manipulate and Distinguish Molecules, Separating Them by the Magnitude of Their Electrical Polarity Which, in Turn, Is Highly Sensitive to the Molecule's 3D Shape.
Molecules May Be Pushed or Pulled by the Fields Depending on Their Orientations in the Field and the Magnitude of Their Polarity (Dipole Moment). Since Molecular Isomers Weigh the Same, Their Identification via Mass Spectrometry Is Complicated and Typically Requires Time-Consuming Method Development Work.
The Proposed Instrument Aims to Reduce This Work by Using Dipole Moments to Distinguish All Isomers and Their Conformers in a Single Spectrum - with an Axis Labeled by Mass-to-Dipole-Moment Ratio, Rather Than Mass-to-Charge Ratio.
This Technology Uses Microfabrication Techniques to Miniaturize and Planarize a Previously Demonstrated Quadrupole Device Described in the Academic Literature, Creating an Array of Microscopic Quadrupole Channels. The Additional Patent-Pending Deceleration Feature, Coupled with Velocity Selective Detection, Should Result in 2-to-3 Orders of Magnitude Higher Isomer/Conformer Discrimination Capabilities Over the Literature Device.
Finally, This Universal Detection Methodology Will Allow for Continuous Throughput, Which Is Ideal for Interfacing with Standard Analytical Instrumentation.
This Award Reflects NSF's Statutory Mission and Has Been Deemed Worthy of Support Through Evaluation Using the Foundation's Intellectual Merit and Broader Impacts Review Criteria.
Awardee
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Greensboro,
North Carolina
27412-5011
United States
Geographic Scope
Single Zip Code
Related Opportunity
None
Moires Instruments was awarded
Project Grant 2208750
worth $256,000
from National Science Foundation in May 2023 with work to be completed primarily in Greensboro North Carolina United States.
The grant
has a duration of 1 year and
was awarded through assistance program 47.084 NSF Technology, Innovation, and Partnerships.
SBIR Details
Research Type
SBIR Phase I
Title
SBIR Phase I:A Radio Frequency Quadrupole Stark Decelerator to Identify Isomers and Conformers and Measure their Effective Dipole Moments
Abstract
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will lead to a new type of analytical instrument and associated businesses, specializing in the identification and characterization of chemical isomers and their different conformational forms (conformers).Isomers are molecules with the same constituent atoms but arranged differently. The identification of isomers and their conformational forms is of critical importance to pharmaceutical and agrochemical industries since the metabolites of many medications or agrochemical compounds are often isomers of one another. Since some of these metabolites may be harmful, safety and efficacy studies require careful analytical “method development” work to quantitate their presence in clinical samples, soils, and foodstuffs.Unfortunately, current analytical methods for identifying molecular isomers are cumbersome, slow, and involve trial and error work – presenting a significant bottleneck to regulatory approval.The proposed technology seeks to provide a rapid and robust instrument for isomer analysis, dramatically reducing pharmaceutical and agrochemical development costs and extending patent exclusivity sales – while enabling the experimental identification of conformers for the first time. Access to this new information has the potential to transform agrochemical ($220 billion total addressable market (TAM) in 2022) and drug discovery ($82 billion TAM 2022) sectors, while generating new well-paying, high-tech jobs._x000D__x000D_ _x000D_ This SBIR Phase I project proposes to develop a novel mass spectrometer that works on neutral molecules rather than ions.It uses high electric fields to manipulate and distinguish molecules, separating them by the magnitude of their electrical polarity which, in turn, is highly sensitive to the molecule’s 3D shape.Molecules may be pushed or pulled by the fields depending on their orientations in the field and the magnitude of their polarity (“dipole moment”).Since molecular isomers weigh the same, their identification via mass spectrometry is complicated and typically requires time-consuming “method development” work. The proposed instrument aims to reduce this work by using dipole moments to distinguish all isomers and their conformers in a single spectrum – with an axis labeled by mass-to-dipole-moment ratio, rather than mass-to-charge ratio. This technology uses microfabrication techniques to miniaturize and planarize a previously demonstrated quadrupole device described in the academic literature, creating an array of microscopic quadrupole channels. The additional patent-pending deceleration feature, coupled with velocity selective detection, should result in 2-to-3 orders of magnitude higher isomer/conformer discrimination capabilities over the literature device. Finally, this universal detection methodology will allow for continuous throughput, which is ideal for interfacing with standard analytical instrumentation._x000D_ _x000D_ This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
Topic Code
CT
Solicitation Number
NSF 21-562
Status
(Complete)
Last Modified 5/19/23
Period of Performance
5/15/23
Start Date
4/30/24
End Date
Funding Split
$256.0K
Federal Obligation
$0.0
Non-Federal Obligation
$256.0K
Total Obligated
Activity Timeline
Additional Detail
Award ID FAIN
2208750
SAI Number
None
Award ID URI
SAI EXEMPT
Awardee Classifications
For-Profit Organization (Other Than Small Business)
Awarding Office
491503 TRANSLATIONAL IMPACTS
Funding Office
491503 TRANSLATIONAL IMPACTS
Awardee UEI
XT7JRZMBDFU7
Awardee CAGE
96CL0
Performance District
06
Senators
Thom Tillis
Ted Budd
Ted Budd
Representative
Kathy Manning
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
Research and Related Activities, National Science Foundation (049-0100) | General science and basic research | Grants, subsidies, and contributions (41.0) | $256,000 | 100% |
Modified: 5/19/23